KM-34, a Novel Antioxidant Compound, Protects against 6-Hydroxydopamine-Induced Mitochondrial Damage and Neurotoxicity-Reference-Cited by-同舟云学术

KM-34, a Novel Antioxidant Compound, Protects against 6-Hydroxydopamine-Induced Mitochondrial Damage and Neurotoxicity

Published:2018-01-02 Issue:2 Volume:36 Page:279-291
ISSN:1029-8428
Container-title:Neurotoxicity Research
language:en
Short-container-title:Neurotox Res

Author:

Fonseca-Fonseca Luis Arturo,Nuñez-Figueredo Yanier,Sánchez Jeney Ramírez,Guerra Maylin Wong,Ochoa-Rodríguez Estael,Verdecia-Reyes Yamila,Hernádez René Delgado,Menezes-Filho Noelio J.,Costa Teresa Cristina Silva,de Santana Wagno Alcântara,Oliveira Joana L.,Segura-Aguilar Juan,da Silva Victor Diogenes Amaral,Costa Silva Lima

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (BR)

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Springer Science and Business Media LLC

Subject

Toxicology,General Neuroscience

Link

http://link.springer.com/content/pdf/10.1007/s12640-017-9851-5.pdf

Reference57 articles.

1. Allbutt HN, Henderson JM (2007) Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson’s disease. J Neurosci Methods 159(2):195–202. https://doi.org/10.1016/j.jneumeth.2006.07.006

2. Berridge MV, Tan AS (1993) Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 303(2):474–482. https://doi.org/10.1006/abbi.1993.1311